pharma · Colorectal Carcinoma · Glioblastoma
photonamic GmbH &
Photonamic GmbH & Co. KG
Photonamic GmbH & is a pharma organization headquartered in EU. Primary therapeutic focus areas include Colorectal Carcinoma, Glioblastoma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent reco
Pinneberg, DE HQ
2002 Founded
26 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Pinneberg, DE
- Founded
- 2002
- Employees
- 26
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Gliolan 30 mg/ml powder for oral solution.
Phase 2 · small molecule · Colorectal Carcinoma
Gliolan 30 mg/ml powder for oral solution. for Colorectal Carcinoma is a Phase 2 program (small_molecule) at Photonamic GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Internal code KRK 01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Photonamic GmbH & Co. KG
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Colorectal Carcinoma
- Status
- active
- Trials
- 1